|
EVERYTHING
Male Investors: Read This Book Instead of Asking Your Wife
What: We sat down with journalist and NYU Stern adjunct Prof. Marina Gerner to discuss her book on the female founders trying to innovate in the business of women’s health. Entitled The Vagina Business, the book isn’t shy about getting into the details—and encourages investors to get over their fears about that, too.
Why it matters: “I’d want [male investors to read the book and] not say to founders, ‘Let me go home and ask my wife.’ Because that’s something founders tell me all the time–they pitch their product to investors, and investors will reply by saying, ‘Oh, you know, let me go home and ask my wife.’ You just wouldn’t do that with any other product. You wouldn’t base a decision on the experiences of one person. You would look at the market, you would look at the statistics. …In other areas, it’s very normal to have advisors as an investor. It would be easy to get a gynecologist to give you advice, and try to get over that personal relatability hurdle.
Source: Maternie
FERTILITY
Despite Trump’s ‘Fertilization’ Ramblings, Senate Republicans Vote Down IVF Protection (Again)
What: Despite Donald Trump proclaiming himself a leader on “fertilization,” Senate Republicans voted down a bill to protect access to IVF treatments nationwide for the *second* time this year. Trump’s running mate, Sen. JD Vance of Ohio, skipped the vote entirely.
Why it matters: “[Sen Tammy] Duckworth’s bill would establish a statutory right for individuals to access in vitro fertilization treatments and empowers the Justice Department to enforce the law. It would also provide access to servicemembers for treatments and counseling and increases affordability for fertility care by requiring insurers in both private and public health care plans to cover treatments.”
Source: NPR
ABORTION ACCESS
Louisiana Hospital Staff are Sprinting (Literally) to Get Drugs Needed for Miscarriages
What: Staff in Louisiana hospitals “are doing timed drills, sprinting from patient rooms and through halls to the locked medicine closets where the drugs used for abortions, incomplete miscarriages and postpartum hemorrhaging will have to be kept — as newly categorized controlled substances — starting Oct. 1.”
Why it matters: “’It adds a few minutes,’ Jennifer Avegno, director of the New Orleans Health Department, said of the looming restrictions. ‘Most patients would likely make it. But I’ve seen myself what can happen when someone is bleeding out from a miscarriage. And a few minutes could mean life and death in some cases.’”
Source: Washington Post
VP Kamala Harris Speaks About Amber Thurman
What: VP Kamala Harris spoke about Amber Thurman, the 28-year-old Georgia mom who died of sepsis when an ER waited too long to remove fetal tissue, on the campaign trail today. It is the first time a presidential nominee has brought attention to an individual who died for lack of routine abortion care.
Why it matters: “’This young mother should be alive, raising her son, and pursuing her dream of attending nursing school,’ Harris said in a statement. ‘Women are bleeding out in parking lots, turned away from emergency rooms, losing their ability to ever have children again. Survivors of rape and incest are being told they cannot make decisions about what happens next to their bodies. And now women are dying. These are the consequences of Donald Trump’s actions.’”
Source: ABC News
MENOPAUSE
Lack of Education Behind Exceeding Low Hormone Therapy?
What: Medscape digs in to the exceedingly low hormone replacement therapy numbers among American women aged 50-59, with less than four percent using the treatment. That is *ten times* lower than the HRT usage rate before a 2002 study (of an ultimately skewed population) scared clinicians into not prescribing HRT for symptoms like hot flashes.
Why it matters: “The lack of education among providers is likely the biggest reason for the decline, Pinkerton says. ‘I think it’s because there’s a whole group of providers that did not receive any training, and that’s OB/GYNs, internal medicine, family practice, endocrinologists,’ she said. ’Now that people are starting to feel more confident that we can use it safely, we’re trying to get that training out to people about vasomotor symptoms, about hormone therapy, and now about new nonhormone therapies.’”
Source: Medscape
|